2018 Safety Specialization 
Pharma Pathway
SEPTEMBER 20, 2022
Eugia Pharma Specialities Limited is Subsidiary of Aurobindo Pharma Limited, Aurobindo Pharma Ltd’ (APL). Billion revenues for 2018-19, with presence in more than 34 countries fronted presence with products exported to 155 nations. Job Description. Email Id: hariprasad.vadlamuri@aurobindo.com / harikrishna.gottumukkala@eugia.co.in.
European Pharmaceutical Review
FEBRUARY 21, 2023
After the substance became legal in the UK in 2018, pharmaceutical companies have faced numerous obstacles to attain a fairer position in the industry. How do you see the evolution of cannabis-based medicines, particularly when it comes to the ‘specials’ or fully licensed drug routes? He founded Celadon in 2018.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharma Marketing Network
OCTOBER 26, 2020
For companies that process “special categorizes of data, through research and clinical trials etc.,” The GDPR requires any company that processes large amounts of special categories of personal data to appoint a data protection officer , either by recruitment of a new employee or via an outsourced data protection officer.
Clarivate
MAY 11, 2023
In parallel, the CDE also established a special channel to facilitate these approvals. Despite the availability of multiple DMTs in the Western markets, there was a dearth of DMTs in Mainland China before 2018. 2] Opinion on the list of new drugs marketed overseas urgently needed in China , August 2018. [3]
PM360
MARCH 22, 2024
“For many years, our expertise in vision technology has been key in developing automotive solutions that improve driver safety,” said Neil Boehm, Chief Technology Officer at Gentex. Welcoming Kate and Denisa represents the culmination of a significant growth period since our inception in 2018.”
European Pharmaceutical Review
DECEMBER 22, 2022
Targeted entry of mRNA into human cells is a challenging process that requires special delivery systems to protect the therapeutic mRNA from degradation…”. The first drug to be approved with an ionised lipid was Onpattro® (patisiran) for the treatment of hereditary transthyretin protein amyloidosis in 2018. Boisguérin P, et a l.
Clarivate
MAY 24, 2022
6] [7] However, in May 2018, the National Health Commission of China (NHC), together with four other national agencies, formulated China’s First List of Rare Diseases (CRDL) to provide a foundation for policymaking around rare disease treatments. 2018; 40:432-434. (in Source: Clarivate analysis. 10] [11] [12]. 10] [11] [12].
Expert insights. Personalized for you.
86 
Let's personalize your content